Oscar Health to reaffirm FY2024 guidance at three investor conferences in Sept 2024

Oscar Health, Inc.

Company participates in Wells Fargo Conference Sept 4, Morgan Stanley Conference Sept 5, and Baird Conference Sept 11.
Management will reaffirm the updated full-year 2024 guidance from the Q2 2024 earnings release (Aug 7, 2024).
Presentations webcast; access details on ir.hioscar.com investor relations page.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.